Vitrivax, Inc is a formulation technology company based in Boulder, CO, dedicated to maximizing global accessibility and utility of human and animal vaccines. They engineer innovative solutions to eliminate barriers to global vaccination, offering thermostable, single-shot vaccines that protect against preventable diseases and save lives.
With their proprietary Atomic Layering Thermostable Antigen and Adjuvant (ALTA) technology platform, Vitrivax has developed a novel approach to address the challenges of maintaining thermostability during transport and storage, as well as the need for multiple doses. Their technology enables the creation of thermostable vaccines that can be administered in a single shot, providing extended shelf life and eliminating the need for cold storage and complex distribution. This breakthrough allows vaccines to reach underserved populations and geographies more easily, contributing to disease prevention and global health.
Generated from the website